CompletedPhase 4ACTRN12606000503527

The effect of propofol or propofol plus midazolam and/or fentanyl on cognitive impairment following colonoscopy

Sponsor

Melbourne Health Research Directorate

Enrollment

200 participants

Start Date

Dec 6, 2006

Study Type

Interventional

Conditions

Patients undergoing colonoscopy

Summary

Patients having colonoscopy under sedation may remain sedated for some hours afterwards. This may mean that they cannot return to work inside or outside the home. Our hypothesis is that patients who receive midazolam and fentanyl, as well as propofol, will be more sedated than those who receive propofol alone, at the time of hospital discharge.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at: The effect of propofol or propofol plus midazolam and/or fentanyl on cognitive impairment following colonoscopy. It is open to Both males and females, aged 18 and older. To take part, you generally need: Patients who present for elective outpatient colonoscopy. There are also some health conditions and factors that may prevent you from joining.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

2. Sedation individually titrated for patient requirement for the duration of colonoscopy (10-60 minutes) with variable dose intravenous propofol (50-400 mg) plus variable dose intravenous midazolam (

Locations(1)

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000503527